Skip to main content
Premium Trial:

Request an Annual Quote

Jim Kent, David Sankoff, Jing Li


The International Society for Computational Biology has announced the 2003 winners of its annual Overton Prize and its first Senior Scientist Accomplishment Award. The Overton Prize, awarded for “outstanding achievement in the field of computational biology by a scientist in the early- to mid-phase of his or her career,” will go to Jim Kent, an assistant research scientist at the University of California, Santa Cruz (see p. 6 for an interview with Kent). The Senior Scientist Accomplishment Award, which honors a career of accomplishment in bioinformatics, will be awarded to David Sankoff, Canada Research Chair in Mathematical Genomics at the University of Ottawa and a member of the Centre de Recherches Mathématiques at the Université de Montréal. Both prizes will awarded at the ISCB’s Intelligent Systems for Molecular Biology conference in Brisbane, Australia, June 29-July 3.

Jing Li, a graduate student at the University of California, Riverside, shared first place in the Association for Computing Machinery Student Research Competition Feb. 19-23 for a bioinformatics project called “Efficient Rule-Based Haplotying Algorithms for Pedigree Data.”

Filed under

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.